This review comprehensively covers recent progresses in the field of OPN with a focus on elucidating its structural features and immune modulatory properties, its role in regulating CAFs, influencing epithelial-mesenchymal transition (EMT), contributing to the enrichment of cancer stem cells (CSCs), promoting metastasis, fostering therapy resistance and influencing metabolic regulation. The gene discussed is SPP1; the disease is cancer.